Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Phesgo 600mg/600mg Injection
Manufacturer/Marketed By : ROCHE PRODUCTS INDIA PVT LTD
$2738.87 $2276.12
Sidmex Inovia offers bulk export supply of Phesgo 600mg/600mg Injection (PERTUZUMAB,TRASTUZUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
PERTUZUMAB,TRASTUZUMAB
Active Pharmaceutical Ingredient
Phesgo 600mg/600mg Injection
$2,738.87
$2,276.12
Sidmex Inovia offers bulk export supply of Phesgo 600mg/600mg Injection (PERTUZUMAB,TRASTUZUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Phesgo 600mg/600mg Injection is a targeted therapy containing the active constituents pertuzumab and trasrtuzumab. It is used to treat a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body (metastasized) or cancer that has come back after the treatment. It will also be given before or after the surgery if the cancer has not metastasized. Cancer occurs when cells begin to grow abnormally in an uncontrolled manner. Before taking Phesgo 600mg/600mg Injection, talk to the physician if you have heart problems, have had radiotherapy, or have allergic conditions. This medication is not recommended for adolescents and children under 18. In patients with early-stage HER2-positive breast cancer, adding pertuzumab or trastuzumab to standard chemotherapy can reduce the risk of recurrence and improve disease-free survival.
Active Pharmaceutical Ingredient
Uses
• Breast cancer
• Non-small cell lung cancer
Benefits
Human epidermal growth factor receptor 2 protein is largely present in some cancer cells and stimulates the growth of cancer cells. Phesgo 600mg/600mg Injection binds selectively to the HER2 receptors on breast cancer cells' surface, blocks them from receiving growth signals, and stops the cancer cells' growth.
Side Effects
Like all medications, Phesgo 600mg/600mg Injections cause some side effects, although not everyone will experience them.
Most Common Side Effects
• Nausea and vomiting
• Diarrhea
• Fatigue
• Hair loss
• Rash or itching
• Muscle pain or weakness
• Headache
• Difficulty sleeping
• Loss of appetite
Common Side Effects
• Pulmonary toxicity (interstitial lung disease or pneumonitis)
• Infusion-related reactions
• Hypersensitivity reactions
• Liver toxicity
• Immune system effects
• Severe allergic reactions
• Gastrointestinal perforation (rare)
• Reduced blood platelets or white blood cell counts
How To Use
Phesgo 600mg/600mg Injection is a medication administered intravenously (IV) by a healthcare professional. It is important to follow the healthcare provider's instructions regarding the dosage and administration of medication. Do not double the dose to make up for missed doses.
Safety Advice
• Breast Feeding: Phesgo 600mg/600mg Injection can cause side effects, and the safety of their use in the lungs depends on several factors. Patients should consult their doctor if they have any pre-existing health condition before taking this medication.
• Alcohol: Alcohol use can negatively affect the immune system, and patients receiving Phesgo 600mg/600mg Injection may already have compromised immune systems due to their medical condition or treatment. Therefore, it is generally recommended that patients limit their alcohol consumption or avoid alcohol entirely while receiving it.
• Liver: Patients with pre-existing liver disease or impaired liver function may be at increased risk for the potential side effects of Phesgo 600mg/600mg Injection, including liver toxicity. So patients should discuss it with their healthcare provider before taking it.
• Lungs: Patients with pre-existing liver disease or impaired liver function may be at increased risk for the potential side effects of Phesgo 600mg/600mg Injection, including liver toxicity. So patients should discuss it with their healthcare provider before taking it.
• Driving: Patients should always monitor their response to the Phesgo 600mg/600mg Injection medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: It is unknown whether Phesgo 600mg/600mg Injection is excreted in human milk. So breastfeeding women should consult their doctor before taking it.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.